Adagene (ADAG) Operating Leases (2022 - 2025)
Adagene's (ADAG) quarterly Operating Leases came in at $53.5 billion in Q4 2025, down 62.42% year-on-year from $142.3 billion in Q4 2024, and up 60289624.37% on a QoQ basis from $88705.0 in Q2 2025.
Adagene (ADAG) Operating Leases (2022 - 2025) Analysis & Trends
Adagene (ADAG) has 4 years of Operating Leases data on file, last reported at $53.5 billion in Q4 2025.
- On a quarterly basis, Operating Leases fell 62.42% year-over-year to $53.5 billion in Q4 2025; TTM through Dec 2025 was $53.5 billion, a 62.42% decrease from a year earlier, with the FY2025 full-year figure at $53.5 billion, down 62.42% from the prior year.
- Operating Leases for Q4 2025 stood at $53.5 billion, up from $88705.0 in the prior quarter.
- Over the last five years, Operating Leases for ADAG reached as high as $173.7 billion in Q4 2023 and fell as low as $88705.0 in Q2 2025.
- Historically, Operating Leases has averaged $86.6 billion across 4 years, with a median of $91.0 billion in 2022.
- Across the five-year window, Operating Leases soared 222.58% in 2023 and tumbled 100.0% in 2024, its largest moves.
- Year by year, Operating Leases stood at $53.8 billion in 2022, then surged by 222.58% to $173.7 billion in 2023, then decreased by 18.06% to $142.3 billion in 2024, then slumped by 62.42% to $53.5 billion in 2025.
- Per Business Quant data, the three most recent Operating Leases figures were $53.5 billion in Q4 2025, $88705.0 in Q2 2025, and $142.3 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.48 Bn |
| Jun 30, 2025 | 88,705.00 |
| Dec 31, 2024 | 142.30 Bn |
| Jun 30, 2024 | 114,086.00 |
| Dec 31, 2023 | 173.66 Bn |
| Jun 30, 2023 | 141.43 Bn |
| Dec 31, 2022 | 53.83 Bn |
| Jun 30, 2022 | 128.08 Bn |